Kosugi S, Miyazawa T, Chou D, Saito Y, Shinbo T, Matsuki A, Okano H, Miyaji C, Watanabe H, Hatakeyama K, Niwa O, Kominami R
First Department of Biochemistry, First Department of Surgery, Department of Immunology, Niigata University School of Medicine, Asahimachi 1-757, Niigata, 951-8122, Japan.
Biochem Biophys Res Commun. 1999 Feb 5;255(1):99-103. doi: 10.1006/bbrc.1999.0142.
Analysis of double mutant mice of the p53 and scid genes, which have a combination of cell cycle checkpoint/apoptosis and DNA repair defects, shows that the latter defect synergistically enhances lymphoma development with loss of the former function. These mice lack the ability to eliminate lymphocytes predisposed to neoplastic transformation resulting from faulty antigen receptor gene rearrangement. Here we examine the cooperativity in double heterozygotes of p53 and scid in which normal development of lymphocytes is not impaired. MSM mice carrying a p53-knockout allele were crossed with BALB/c mice heterozygous for the scid locus and 129 offspring were obtained. They were subjected to gamma-ray irradiation, 84 thymic lymphomas being generated. The tumors and host mice were genotyped of p53 and scid. Among 42 mice developing p53-deficient lymphomas, scid/+ and +/+ genotypes did not provide difference in onset and latency. Besides, allelic loss of the Scid gene occurred at a high frequency in those lymphomas but the loss exhibited no allelic bias. The results suggest that the scid/+ genotype is not a modifier of loss of p53 function in the double heterozygotes.
对p53和scid基因的双突变小鼠进行分析,这些小鼠兼具细胞周期检查点/凋亡和DNA修复缺陷,结果显示后一种缺陷与前一种功能丧失协同增强淋巴瘤的发展。这些小鼠缺乏清除因抗原受体基因重排错误而易于发生肿瘤转化的淋巴细胞的能力。在此,我们研究了p53和scid双杂合子中的协同作用,其中淋巴细胞的正常发育未受损害。携带p53敲除等位基因的MSM小鼠与scid位点杂合的BALB/c小鼠杂交,获得了129只后代。对它们进行γ射线照射,产生了84例胸腺淋巴瘤。对肿瘤和宿主小鼠进行p53和scid基因分型。在42只发生p53缺陷型淋巴瘤的小鼠中,scid/+和+/+基因型在发病和潜伏期方面没有差异。此外,Scid基因的等位基因缺失在这些淋巴瘤中高频发生,但这种缺失没有等位基因偏向性。结果表明,scid/+基因型不是双杂合子中p53功能丧失的修饰因子。